Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
NRIM vs BSVN vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
NRIM vs BSVN vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $558M | $438M | $908.57B |
| Revenue (TTM) | $243M | $137M | $280.33B |
| Net Income (TTM) | $65M | $43M | $57.05B |
| Gross Margin | 81.4% | 69.7% | 60.0% |
| Operating Margin | 35.5% | 41.4% | 25.9% |
| Forward P/E | 9.7x | 10.3x | 14.6x |
| Total Debt | $94M | $0.00 | $942.38B |
| Cash & Equiv. | $36M | $245M | $343.34B |
NRIM vs BSVN vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Northrim BanCorp, I… (NRIM) | 100 | 400.8 | +300.8% |
| Bank7 Corp. (BSVN) | 100 | 420.3 | +320.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 345.8 | +245.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NRIM vs BSVN vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NRIM is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 16 yrs, beta 0.88, yield 2.6%
- Rev growth 23.8%, EPS growth 72.9%
- PEG 0.55 vs JPM's 0.83
BSVN carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.60, current ratio 502.78x
- Beta 0.60, yield 2.1%, current ratio 502.78x
- NIM 4.5% vs JPM's 2.2%
JPM is the clearest fit if your priority is long-term compounding.
- 481.2% 10Y total return vs NRIM's 355.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.8% NII/revenue growth vs BSVN's -3.9% | |
| Value | Lower P/E (9.7x vs 14.6x), PEG 0.55 vs 0.83 | |
| Quality / Margins | Efficiency ratio 0.3% vs NRIM's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.60 vs NRIM's 0.88 | |
| Dividends | 2.6% yield, 16-year raise streak, vs BSVN's 2.1% | |
| Momentum (1Y) | +23.2% vs NRIM's +18.3% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NRIM's 0.5% |
NRIM vs BSVN vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NRIM vs BSVN vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — NRIM and BSVN each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 2042.4x BSVN's $137M. BSVN is the more profitable business, keeping 31.4% of every revenue dollar as net income compared to JPM's 20.4%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $243M | $137M | $280.3B |
| EBITDAEarnings before interest/tax | $89M | $58M | $81.4B |
| Net IncomeAfter-tax profit | $65M | $43M | $57.0B |
| Free Cash FlowCash after capex | $134M | $36M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +81.4% | +69.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +35.5% | +41.4% | +25.9% |
| Net MarginNet income ÷ Revenue | +26.6% | +31.4% | +20.4% |
| FCF MarginFCF ÷ Revenue | +55.2% | +26.4% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +12.8% | -3.4% | +16.0% |
Valuation Metrics
NRIM leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 8.8x trailing earnings, NRIM trades at a 46% valuation discount to JPM's 16.2x P/E. Adjusting for growth (PEG ratio), NRIM offers better value at 0.50x vs JPM's 0.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $558M | $438M | $908.6B |
| Enterprise ValueMkt cap + debt − cash | $615M | $194M | $1.51T |
| Trailing P/EPrice ÷ TTM EPS | 8.78x | 10.14x | 16.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.73x | 10.27x | 14.60x |
| PEG RatioP/E ÷ EPS growth rate | 0.50x | 0.60x | 0.92x |
| EV / EBITDAEnterprise value multiple | 6.93x | 3.34x | 18.52x |
| Price / SalesMarket cap ÷ Revenue | 2.30x | 3.19x | 3.25x |
| Price / BookPrice ÷ Book value/share | 1.74x | 1.74x | 2.51x |
| Price / FCFMarket cap ÷ FCF | 4.17x | 10.59x | 9.01x |
Profitability & Efficiency
Evenly matched — NRIM and BSVN each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
NRIM delivers a 21.3% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $16 for JPM. NRIM carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), NRIM scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +21.3% | +18.2% | +15.9% |
| ROA (TTM)Return on assets | +2.0% | +2.3% | +1.3% |
| ROICReturn on invested capital | +17.7% | +18.3% | +4.5% |
| ROCEReturn on capital employed | +4.7% | +5.2% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.29x | — | 2.60x |
| Net DebtTotal debt minus cash | $58M | -$245M | $599.0B |
| Cash & Equiv.Liquid assets | $36M | $245M | $343.3B |
| Total DebtShort + long-term debt | $94M | $0 | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.01x | 1.39x | 0.74x |
Total Returns (Dividends Reinvested)
BSVN leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BSVN five years ago would be worth $29,019 today (with dividends reinvested), compared to $23,548 for JPM. Over the past 12 months, BSVN leads with a +23.2% total return vs NRIM's +18.3%. The 3-year compound annual growth rate (CAGR) favors NRIM at 38.7% vs BSVN's 25.7% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -5.0% | +11.6% | +0.8% |
| 1-Year ReturnPast 12 months | +18.3% | +23.2% | +20.9% |
| 3-Year ReturnCumulative with dividends | +166.6% | +98.7% | +138.8% |
| 5-Year ReturnCumulative with dividends | +167.7% | +190.2% | +135.5% |
| 10-Year ReturnCumulative with dividends | +355.8% | +166.3% | +481.2% |
| CAGR (3Y)Annualised 3-year return | +38.7% | +25.7% | +33.7% |
Risk & Volatility
Evenly matched — BSVN and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
BSVN is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than NRIM's 0.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs NRIM's 81.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.88x | 0.60x | 0.87x |
| 52-Week HighHighest price in past year | $30.82 | $50.10 | $338.09 |
| 52-Week LowLowest price in past year | $19.60 | $37.56 | $269.72 |
| % of 52W HighCurrent price vs 52-week peak | +81.8% | +91.1% | +96.2% |
| RSI (14)Momentum oscillator 0–100 | 52.9 | 58.8 | 72.1 |
| Avg Volume (50D)Average daily shares traded | 116K | 12K | 7.4M |
Analyst Outlook
NRIM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NRIM as "Buy", BSVN as "Buy", JPM as "Buy". Consensus price targets imply 24.9% upside for BSVN (target: $57) vs 4.5% for JPM (target: $340). For income investors, NRIM offers the higher dividend yield at 2.56% vs JPM's 1.83%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $57.00 | $339.75 |
| # AnalystsCovering analysts | 1 | 3 | 61 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | +2.1% | +1.8% |
| Dividend StreakConsecutive years of raises | 16 | 7 | 15 |
| Dividend / ShareAnnual DPS | $0.65 | $0.98 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.3% | +3.8% |
NRIM leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). BSVN leads in 1 (Total Returns). 3 tied.
NRIM vs BSVN vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NRIM or BSVN or JPM a better buy right now?
For growth investors, Northrim BanCorp, Inc.
(NRIM) is the stronger pick with 23. 8% revenue growth year-over-year, versus -3. 9% for Bank7 Corp. (BSVN). Northrim BanCorp, Inc. (NRIM) offers the better valuation at 8. 8x trailing P/E (9. 7x forward), making it the more compelling value choice. Analysts rate Northrim BanCorp, Inc. (NRIM) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NRIM or BSVN or JPM?
On trailing P/E, Northrim BanCorp, Inc.
(NRIM) is the cheapest at 8. 8x versus JPMorgan Chase & Co. at 16. 2x. On forward P/E, Northrim BanCorp, Inc. is actually cheaper at 9. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Northrim BanCorp, Inc. wins at 0. 55x versus JPMorgan Chase & Co. 's 0. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NRIM or BSVN or JPM?
Over the past 5 years, Bank7 Corp.
(BSVN) delivered a total return of +190. 2%, compared to +135. 5% for JPMorgan Chase & Co. (JPM). Over 10 years, the gap is even starker: JPM returned +481. 2% versus BSVN's +166. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NRIM or BSVN or JPM?
By beta (market sensitivity over 5 years), Bank7 Corp.
(BSVN) is the lower-risk stock at 0. 60β versus Northrim BanCorp, Inc. 's 0. 88β — meaning NRIM is approximately 47% more volatile than BSVN relative to the S&P 500. On balance sheet safety, Northrim BanCorp, Inc. (NRIM) carries a lower debt/equity ratio of 29% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — NRIM or BSVN or JPM?
By revenue growth (latest reported year), Northrim BanCorp, Inc.
(NRIM) is pulling ahead at 23. 8% versus -3. 9% for Bank7 Corp. (BSVN). On earnings-per-share growth, the picture is similar: Northrim BanCorp, Inc. grew EPS 72. 9% year-over-year, compared to -7. 0% for Bank7 Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NRIM or BSVN or JPM?
Bank7 Corp.
(BSVN) is the more profitable company, earning 31. 4% net margin versus 20. 4% for JPMorgan Chase & Co. — meaning it keeps 31. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BSVN leads at 41. 4% versus 26. 0% for JPM. At the gross margin level — before operating expenses — NRIM leads at 81. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NRIM or BSVN or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Northrim BanCorp, Inc. (NRIM) is the more undervalued stock at a PEG of 0. 55x versus JPMorgan Chase & Co. 's 0. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Northrim BanCorp, Inc. (NRIM) trades at 9. 7x forward P/E versus 14. 6x for JPMorgan Chase & Co. — 4. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BSVN: 24. 9% to $57. 00.
08Which pays a better dividend — NRIM or BSVN or JPM?
All stocks in this comparison pay dividends.
Northrim BanCorp, Inc. (NRIM) offers the highest yield at 2. 6%, versus 1. 8% for JPMorgan Chase & Co. (JPM).
09Is NRIM or BSVN or JPM better for a retirement portfolio?
For long-horizon retirement investors, Bank7 Corp.
(BSVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60), 2. 1% yield, +166. 3% 10Y return). Both have compounded well over 10 years (BSVN: +166. 3%, NRIM: +355. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NRIM and BSVN and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NRIM is a small-cap high-growth stock; BSVN is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.